Krystal Biotech (KRYS) stock gains as the company wins FDA RMAT designation for its lung cancer therapy KB707. Read more here ...
Aerska, a startup developing treatments to silence the problematic genes that cause various brain diseases, has raised $39 ...
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...
The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...
The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.
The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...
A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for betting on the ...
The business may not be as strong as its performance this year suggests.
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results